CRHR2 and post-traumatic stress disorder: While we decided on immediate IN application of the CRHR2 agonist after the SPS protocol, in future experiments, it will be necessary to investigate whether the IN application of the CRHR2 agonist days or weeks after stressful events has the potential to ameliorate manifestations of PTSD symptoms.